CME Program Detail

Title: The 13th Annual Neonatal Symposium: Updates on Current Management of EOS, PDA, BPD and RDS in the NICU
Date: Thu, Oct 11th, 2018
Time: 8:00 am - 12:45 pm
Location: Lang Auditorium

Statement of Need:
The Neonatal Symposium brings together respected leaders in newborn medicine to illuminate current issues and challenges in neonatal and perinatal health. Presentations will include evidence-based updates in neonatal medicine highlighting: new recommendations in the management of Early-Onset Sepsis (EOS), transcatheter interventions in the management of Patent Ductus Arteriosus (PDA), management of Bronchopulmonary Dysplasia (BPD), and advances in less invasive surfactant administration. Symposium attendees will have the opportunity to review current and important neonatal and perinatal topics of interest to further optimal patient outcomes.

Target Audience:
Neonatologists, pediatricians, obstetricians, neonatal nurse practitioners, neonatal nurses, OB physician assistants, neonatal physician assistants


James J. Cummings, MD, FAAP
Professor of Pediatrics
Vice Chair for Faculty Development
Albany Medical Center

Ralf J. Holzer, MD, MSc, FACC, FSCAI
David Wallace – Starr Foundation Professor of Pediatric Cardiology
Chief, Division of Pediatric Cardiology
Weill Cornell Medicine
Director, Pediatric Cardiac Catheterization
NewYork-Presbyterian/Komansky Children’s Hospital

Matthew M. Laughon, MD, MPH
Professor with Tenure, Department of Pediatrics
Division of Neonatal-Perinatal Medicine
The University of North Carolina at Chapel Hill
Clinical Affiliate, Department of Medicine, Pediatrics-Neonatology, Moore Regional Hospital

Karen M. Puopolo, MD, PhD
Associate Professor of Pediatrics
University of Pennsylvania Perelman School of Medicine
Chief, Section on Newborn Medicine
The Children's Hospital of Philadelphia Newborn Care at Pennsylvania Hospital
Disclosures: None


Pinchi S. Srinivasan, MD, MBA, FAAP
Associate Professor of Clinical Pediatrics
Weill Cornell Medicine
Director of Neonatology
NewYork-Presbyterian Queens

Michael D. Brandler, MD, FAAP
Assistant Professor of Clinical Pediatrics
Weill Cornell Medicine
Associate Director of Neonatology
NewYork-Presbyterian Queens


• Review the current epidemiology and microbiology of EOS.
• Describe the development of the Sepsis Risk Calculator for EOS risk assessment.
• Describe implementation and outcomes of using the Sepsis Risk Calculator for EOS risk management.
• Specify site differences in BPD outcomes and management.
• Identify evidence-based drugs useful in preventing BPD.
• Identify trial designs used in developing drugs to prevent BPD.
• Describe non-medical treatment options for PDA closure.
• Describe technical considerations and limitations of the transcatheter approach.
• Compare adverse events and outcomes of surgical and transcatheter PDA closure.
• Delineate indications for transcatheter versus surgical PDA closure.
• Discuss the advantages and challenges of non-invasive surfactant administration for preterm infants.
• Describe non-invasive methods of surfactant administration, and the strengths/weaknesses of each.
• Summarize the current evidence-base for non-invasive surfactant delivery in preterm infants with RDS.


8:00-8:45 a.m.
Registration & Continental Breakfast
8:45-9:00 a.m.
Welcome/Introductory Remarks
Jaclyn A. Mucaria, MPA - President, NewYork-Presbyterian Queens
Amir Jaffer, MD, MBA - Chief Medical Officer, NewYork-Presbyterian Queens
Joseph J. Abularrage, MD, MPH, M.Phil, FAAP
Professor of Clinical Pediatrics; Assistant Dean (NewYork-Presbyterian Queens)
Liaison for Curricular Projects, Office of Academic Affairs, Weill Cornell Medicine
Chairman, Department of Pediatrics, NewYork-Presbyterian Queens

9:00-9:45 a.m.
Management of Risk for Early-Onset Neonatal Sepsis Among Term Infants
Karen M. Puopolo, MD, PhD

9:45-10:30 a.m.
Prevention and Management of BPD in the New Millennium
Matthew M. Laughon, MD, MPH

10:30-10:40 a.m.
Question and Answer Period

10:40-10:55 a.m.

10:55-11:40 a.m.
Surgical and Transcatheter Treatment for PDA in Premature Infants
Ralf J. Holzer, MD, MSc, FACC, FSCAI

11:40-12:25 p.m.
Advances in Less Invasive Surfactant Administration in VLBW Infants
James J. Cummings, MD, FAAP

12:25-12:35 p.m.
Question and Answer Period

12:35-12:45 p.m.
Closing Remarks

NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

NewYork Presbyterian/Queens designates this Live Activity for a maximum of 3.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.

<< Back to Programs List

<< Back to Program Archive